BioSpace News Archive

Aquestive Therapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, announced that management will present at Oppenheimer’s 29th Annual Healthcare Conference to be held in New York, NY on March 19 - 20.

Twice as Many People Are Living with MS in the US Than Previously Thought

Amgen will present at the Cowen and Company 39th Annual Healthcare Conference at 9:20 a.m. ET on Tuesday, March 12, 2019, in Boston.

Next interim OS assessment for Phase 3 E2112 trial in HR+, HER2- metastatic breast cancer expected in 2Q19

DURECT Corporation announced financial results for the three months and year ended December 31, 2018 and provided a corporate update.

Triple-S Management Corporation announced that its President and Chief Executive Officer Roberto García-Rodríguez, and its EVP and Chief Financial Officer Juan José Román-Jiménez will present at the Barclays Global Healthcare Conference on Thursday, March 14, 2019 at the Loews Miami Beach Hotel in Miami Beach, FL.

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that management will present a company overview at the Cowen & Company 39th Annual Health Care Conference on Wednesday, March 13, 2019 at 11:20 am ET at the Marriott Copley Place in Boston.

2018 Total Revenue was $22.5 million, with 2018 Product Sales surpassing $20M for the first time, representing 51% growth over 2017

Reports Record Revenues and Reimbursement Pipeline for the Fourth Quarter and Full Year

Deadly diseases that should only be seen in history books are showing up in our hospitals. AIDS Healthcare Foundation takes a stance on what the World Health Organization now lists as one of the top 10 global threats of 2019.